EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cationic Nanogel Coated Norovirus VLP Nasal Vaccine Induces Neutralizing Mucosal IgA and Serum IgG Antibodies

Yoshikazu Yuki iD, Shiho Kurokawa, Tomoyuki Yamanoue, Tomoya Tsuchihashi, Shigeyuki Tamiya, Shin-Ichi Sawada, Yohei Uchida, Kotomi Sugiura, Rika Nakahashi-Ouchida, Naomi Sakon, Daisuke Tokuhara, Kazunari Akiyoshi und 2 weitere

Molecular Pharmaceutics · 06.04.2026 · 23 (4) · 2682-2692

DOI: 10.1021/acs.molpharmaceut.5c01806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.03.2026. Verfasst von Yoshikazu Yuki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba 260-8670, Japan. Hauptthemen laut MEDLINE: Norovirus, Immunoglobulin A, Immunoglobulin G, Vaccines, Virus-Like Particle. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NorovirusImmunoglobulin AImmunoglobulin GVaccines, Virus-Like ParticleNanogelsAntibodies, NeutralizingViral VaccinesAnimalsMiceAdministration, IntranasalFemaleMice, Inbred BALB CAntibodies, ViralNasal MucosaPolyethyleneiminePolyethylene GlycolsCationsNanovaccinesHumansCaliciviridae Infections

Stichwörter der Autor:innen

VLP vaccinecCHP nanogelnanogel-covered nasal vaccinenorovirusvaccine DDSvaccine development

Substanzen

Immunoglobulin AImmunoglobulin GVaccines, Virus-Like ParticleNanogelsAntibodies, ViralAntibodies, NeutralizingPolyethyleneiminepolyethylene glycol polyethyleneimine nanogelPolyethylene GlycolsCations

Autor:innen und Institutionen

  • Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba 260-8670, Japan.
  • Wakayama Medical University, Wakayama 641-8509, Japan.
  • Department of Pediatrics, Wakayama Medical University, Wakayama 641-8509, Japan.
  • Department of Microbiology and Immunology, School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama 640-8156, Japan.
  • Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba 269-8670, Japan.
  • Department of Microbiology, Osaka Institute of Public Health, Osaka 537-0025, Japan.

ORCID-Profile: Yoshikazu Yuki

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Yuki, Y., Kurokawa, S., Yamanoue, T., Tsuchihashi, T., Tamiya, S., Sawada, S. I., Uchida, Y., Sugiura, K., Nakahashi-Ouchida, R., Sakon, N., Tokuhara, D., Akiyoshi, K., Sato, S., & Kiyono, H. (2026). Cationic Nanogel Coated Norovirus VLP Nasal Vaccine Induces Neutralizing Mucosal IgA and Serum IgG Antibodies. Molecular Pharmaceutics, 23(4), 2682-2692. https://doi.org/10.1021/acs.molpharmaceut.5c01806

Vancouver

Yuki Y, Kurokawa S, Yamanoue T, Tsuchihashi T, Tamiya S, Sawada SI, et al. Cationic Nanogel Coated Norovirus VLP Nasal Vaccine Induces Neutralizing Mucosal IgA and Serum IgG Antibodies. Molecular Pharmaceutics. 2026;23(4):2682-2692. doi:10.1021/acs.molpharmaceut.5c01806

BibTeX
@article{Yuki2026,
  author = {Yuki, Yoshikazu and Kurokawa, Shiho and Yamanoue, Tomoyuki and Tsuchihashi, Tomoya and Tamiya, Shigeyuki and Sawada, Shin-Ichi and Uchida, Yohei and Sugiura, Kotomi and Nakahashi-Ouchida, Rika and Sakon, Naomi and Tokuhara, Daisuke and Akiyoshi, Kazunari and Sato, Shintaro and Kiyono, Hiroshi},
  title = {Cationic Nanogel Coated Norovirus VLP Nasal Vaccine Induces Neutralizing Mucosal IgA and Serum IgG Antibodies},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {4},
  pages = {2682--2692},
  doi = {10.1021/acs.molpharmaceut.5c01806}
}
Kostenlos starten →